Janssen Pharmaceutica N.V.
Clinical trials sponsored by Janssen Pharmaceutica N.V., explained in plain language.
A pharmaceutical company and subsidiary of Johnson & Johnson, developing and marketing drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Alzheimer's vaccine trial aims to stop brain protein buildup Results expected Dec 2026 (estimated)
- Psoriatic arthritis drug showdown: which treatment do patients stick with? Results expected Aug 2027 (estimated)